Results 91 to 100 of about 25,204 (165)

ctDNA MRD after CAR-T

Blood Advances
Salvatore Fiorenza, Mark R. Dowling
openaire   +2 more sources

Circulating tumor DNA in appendiceal malignancies: a comprehensive review of clinical applications and limitations. [PDF]

Front Oncol
McKee KE, Oh J, Ruff SM.
europepmc   +1 more source

Circulating tumor DNA in body fluids for molecular characterization of cancers beyond tissue and blood. [PDF]

iScience
Shreenivas A, Limaye S, Cristofanilli M, Lechner M, Gaya AM, Crook T, Leite P, Mokbel K, Schaffrin-Nabe D, Al-Shamsi HO, Patil D, Datar R, Kurzrock R.   +12 more
europepmc   +1 more source

Dynamic Changes of ctDNA-Based MRD and Genomic Mutations Predict Prognosis in ESCC Treated With Definitive Radiotherapy. [PDF]

Cancer Sci
Liu S, Wang Q, Han C, Li X, Cheng R, Liu L, Dong H, Ren X, Zhen S, Wang L.   +9 more
europepmc   +1 more source

Tumor-Informed ddPCR for Personalized Longitudinal ctDNA Monitoring in Advanced Solid Tumors: Molecular-Radiological Concordance and Molecular Lead Time. [PDF]

Int J Mol Sci
Akolkar D, Puranik S, Apurwa S, Chaudhari S, Nandre P, Puranik S, Rao V, Dhasarathan R, Srivastava N, Patil D, Datta V, Kumar P, Page R, Schuster S, Srinivasan A, Datar R.   +15 more
europepmc   +1 more source

A streamlined hybrid-capture and genome-wide multi-omic platform for highly sensitive ctDNA minimal residual disease monitoring. [PDF]

J Liq Biopsy
Nguyen T, Nguyen Hoang VA, Huynh C, Nguyen V, Le SH, Trac QT, Nguyen Hoang TP, Dao NA, Nguyen MTB, Tran NH, Phan DM, Giang H, Nguyen HN, Tu LN.   +13 more
europepmc   +1 more source

Beyond SANO: the future of active surveillance for oesophageal cancer. [PDF]

Br J Surg
Wang J, Liang F, Pang Q, Hui Z.
europepmc   +1 more source

ctDNA-based detection of residual disease: implications for management of non-metastatic NSCLC. [PDF]

Front Oncol
Leclercq C, Wespiser M, Tachon G, Buisson A, Pérol M, Swalduz A.   +5 more
europepmc   +1 more source